Assessing pneumococcal meningitis association with viral respiratory infections and antibiotics: Insights from statistical and mathematical models

Proceedings of the Royal Society B: Biological Sciences

Volumn 280, Issue 1764, 2013, Pages

  Opatowski, Lulla ^a,b,c,d   Varon, Emmanuelle ^e   Dupont, Claire ^a   Temime, Laura ^f   van der Werf, Sylvie ^a,g,h   Gutmann, Laurent ^e   Boëlle, Pierre Yves ^b,i,j   Watier, Laurence ^a,b,c,k   Guillemot, Didier ^a,b,c,k  

^a INSTITUT PASTEUR   (France)

^b INSERM   (France)

^c University Versailles Saint Quentin UVSQ   (France)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

^e HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^f University of Paris Cité   (France)

^g Institut Pasteur   (France)

^h Sorbonne Paris Cité   (France)

ⁱ UMR S 707   (France)

^j ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^k RAYMOND POINCARÉ HOSPITAL   (France)

more..

Author keywords

Antibiotic resistance fitness cost; Influenza; Mathematical model; Statistical model; Streptococcus pneumonia meningitis; Virus bacteria interaction

Indexed keywords

ANTIBIOTICS; DATA ACQUISITION; DISEASE TREATMENT; EPIDEMIC; FITNESS; HEALTH CARE; INFECTIOUS DISEASE; MICROBIAL COMMUNITY; NUMERICAL MODEL; PATHOGEN; RESPIRATORY DISEASE; SIMULATION; STATISTICAL ANALYSIS; TIME SERIES; VACCINATION; VIRAL DISEASE;

BACTERIA (MICROORGANISMS); STREPTOCOCCUS; STREPTOCOCCUS PNEUMONIAE;

EID: 84880958927     PISSN: 09628452     EISSN: 14712954     Source Type: Journal    
DOI: 10.1098/rspb.2013.0519     Document Type: Article

References (51)

1. WHO 2007 Pneumococcal conjugate vaccine for childhood immunization. Wkly Epidemiol. Rec. 82, 93-104.
2. Swartz MN. 2004 Bacterial meningitis: a view of the past 90 years. N. Engl. J. Med. 351, 1826-1828. (doi:10.1056/NEJMp048246)
3. Weisfelt M, de Gans J, van der Poll T, van de Beek D. 2006 Pneumococcal meningitis in adults: new approaches to management and prevention. Lancet Neurol. 5, 332-342. (doi:10.1016/S1474-4422(06)70409-4)
4. Thigpen MC et al. 2011 Bacterial meningitis in the United States, 1998-2007. N. Engl. J. Med. 364, 2016-2025. (doi:10.1056/NEJMoa1005384)
5. Levy C, Varon E, Bingen E, Picard C, de La Rocque F, Aujard Y, Cohen R. 2008 [Pneumococcal meningitis in children in France: 832 cases from 2001 to 2007]. Arch. Pediatr. 15(Suppl. 3), S111-S118. (doi:10. 1016/S0929-693X(08)75493-9)
6. Whitney CG et al. 2000 Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. N. Engl. J. Med. 343, 1917-1924. (doi:10.1056/NEJM200012283432603)
7. Whitney CG et al. 2003 Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N. Engl. J. Med. 348, 1737-1746. (doi:10.1056/ NEJMoa022823)
8. Finkelstein JA et al. 2008 Impact of a 16-community trial to promote judicious antibiotic use in Massachusetts. Pediatrics 121, e15-e23. (doi:10. 1542/peds.2007-0819)
9. Tsai CJ, Griffin MR, Pekka Nuorti J, Grijalva CG. 2008 Changing epidemiology of pneumococcal meningitis after the introduction of pneumococcal conjugate vaccine in the United States. Clin. Infect. Dis. 46, 1664-1672. (doi:10.1086/587897)
10. Talbot TR, Poehling KA, Hartert TV, Arbogast PG, Halasa NB, Edwards KM, Schaffner W, Craig AS, Griffin MR. 2005 Seasonality of invasive pneumococcal disease: temporal relation to documented influenza and respiratory syncytial viral circulation. Am. J. Med. 118, 285-291. (doi:10. 1016/j. amjmed.2004.09.016)
11. Goossens H. 2009 Antibiotic consumption and link to resistance. Clin. Microbiol. Infect. 15(Suppl. 3), 12-15. (doi:10.1111/j.1469-0691.2009.02725. x)
12. Guillemot D, Varon E, Bernede C, Weber P, Henriet L, Simon S, Laurent C, Lecoeur H, Carbon C. 2005 Reduction of antibiotic use in the community reduces the rate of colonization with penicillin Gnonsusceptible Streptococcus pneumoniae. Clin. Infect. Dis. 41, 930-938. (doi:10.1086/432721)
13. Weinberger DM, Malley R, Lipsitch M. 2011 Serotype replacement in disease after pneumococcal vaccination. Lancet 378, 1962-1973. (doi:10.1016/ S0140-6736(10)62225-8).
14. Keeling MJ, Rohani P. 2008 Modeling infectious diseases in humans and animals. Princeton, NJ: Princeton University Press.
15. Vasco DA, Wearing HJ, Rohani P. 2007 Tracking the dynamics of pathogen interactions: modeling ecological and immune-mediated processes in a two-pathogen single-host system. J. Theor. Biol. 245, 9-25. (doi:10.1016/j. jtbi.2006.08.015)
16. Short KR, Habets MN, Hermans PW, Diavatopoulos DA. 2012 Interactions between Streptococcus pneumoniae and influenza virus: a mutually beneficial relationship? Future Microbiol. 7, 609-624. (doi:10.2217/fmb.12.29)
17. Murdoch DR, Jennings LC. 2009 Association of respiratory virus activity and environmental factors with the incidence of invasive pneumococcal disease. J. Infect. 58, 37-46. (doi:10.1016/j. jinf. 2008.10.011)
18. Kuster SP, Tuite AR, Kwong JC, McGeer A, Fisman DN. 2011 Evaluation of coseasonality of influenza and invasive pneumococcal disease: results from prospective surveillance. PLoS Med. 8, e1001042. (doi:10.1371/journal. pmed.1001042)
19. Brundage JF. 2006 Interactions between influenza and bacterial respiratory pathogens: implications for pandemic preparedness. Lancet Infect. Dis. 6, 303-312. (doi:10.1016/S1473-3099(06)70466-2)
20. McCullers JA, McAuley JL, Browall S, Iverson AR, Boyd KL, Henriques Normark B. 2010 Influenza enhances susceptibility to natural acquisition of and disease due to Streptococcus pneumoniae in ferrets. J. Infect. Dis. 202, 1287-1295. (doi:10.1086/ 656333)
21. Davis BM, Aiello AE, Dawid S, Rohani P, Shrestha S, Foxman B. 2012 Influenza and community-acquired pneumonia interactions: the impact of order and time of infection on population patterns. Am. J. Epidemiol. 175, 363-367. (doi:10.1093/ aje/kwr402)
22. Perrocheau A, Scarlett G, Laurent E. 2004 É pidémiologie des méningites bactériennes en France en 2002: Méningites bactériennes communautaires [epidemiology of bacterial meningitis in France in 2002: bacterial meningitis]. La Revue du Praticien 54, 945-950.
23. Sabuncu E, David J, Bernede-Bauduin C, Pepin S, Leroy M, Boelle PY, Watier L, Guillemot D. 2009 Significant reduction of antibiotic use in the community after a nationwide campaign in France, 2002-2007. PLoS Med. 6, e1000084. (doi:10.1371/ journal. pmed.1000084)
24. Perrocheau A, Doyle A, Bernillon P, Varon E. 2006 Estimation du nombre total de méningites à pneumocoque de l'enfant, par la méthode capturerecapture à 3 sources, France, 2001-2002. Bull. Epidémiol. Hebdomadaire 2-3, 16-18.
25. Varon E, Gutmann L. 2001-2004 Centre National de Référence des Pneumocoques. Rapport d'activité. See http://www.invs.sante.fr/Espace-professionnels/ Centres-nationaux-de-reference/Rapports-dactivites-et-liens.
26. Fouillet A, Rey G, Jougla E, Frayssinet P, Bessemoulin P, Hemon D. 2007 A predictive model relating daily fluctuations in summer temperatures and mortality rates. BMC Public Health 7, 114. (doi:10.1186/1471-2458-7-114)
27. Hubert B, Watier L, Garnerin P, Richardson S. 1992 Meningococcal disease and influenza-like syndrome: a new approach to an old question. J. Infect. Dis. 166, 542-545. (doi:10.1093/infdis/166.3.542)
28. Pan W. 2001 Akaike's information criterion in generalized estimating equations. Biometrics 57, 120-125. (doi:10.1111/j.0006-341X.2001.00120. x)
29. Ekdahl K, Ahlinder I, Hansson HB, Melander E, Molstad S, Soderstrom M, Persson K. 1997 Duration of nasopharyngeal carriage of penicillin-resistant Streptococcus pneumoniae: experiences from the south Swedish pneumococcal intervention project. Clin. Infect. Dis. 25, 1113-1117. (doi:10.1086/ 516103)
30. Melegaro A, Gay NJ, Medley GF. 2004 Estimating the transmission parameters of pneumococcal carriage in households. Epidemiol. Infect. 132, 433-441. (doi:10.1017/S0950268804001980)
31. Cauchemez S, Temime L, Valleron AJ, Varon E, Thomas G, Guillemot D, Boelle PY. 2006 S. pneumoniae transmission according to inclusion in conjugate vaccines: Bayesian analysis of a longitudinal follow-up in schools. BMC Infect. Dis. 6, 14. (doi:10.1186/1471-2334-6-14)
32. Hogberg L, Geli P, Ringberg H, Melander E, Lipsitch M, Ekdahl K. 2007 Age-and serogroup-related differences in observed durations of nasopharyngeal carriage of penicillin-resistant pneumococci. J. Clin. Microbiol. 45, 948-952. (doi:10.1128/JCM.01913-06)
33. Institut de veille sanitaire (InVS). 2006 Calendrier vaccinal 2006. Bull. Epidémiol. Hebdomadaire 29-30, 212.
34. Regev-Yochay G, Raz M, Dagan R, Porat N, Shainberg B, Pinco E, Keller N, Rubinstein E. 2004 Nasopharyngeal carriage of Streptococcus pneumoniae by adults and children in community and family settings. Clin. Infect. Dis. 38, 632-639. (doi:10.1086/381547)
35. Opatowski L, Temime L, Varon E, Leclerc R, Drugeon H, Boelle PY, Guillemot D. 2008 Antibiotic innovation may contribute to slowing the dissemination of multiresistant Streptococcus pneumoniae: the example of ketolides. PLoS ONE 3, e2089. (doi:10.1371/journal. pone.0002089)
36. Hannoun C, Dab W, Cohen JM. 1989 A new influenza surveillance system in France: the Ile-de-France 'GROG'. I. Principles and methodology. Eur. J. Epidemiol. 5, 285-293. (doi:10.1007/ BF00144828)
37. Jansen AG, Sanders EA, Van Der Ende A, Van Loon AM, Hoes AW, Hak E. 2008 Invasive pneumococcal and meningococcal disease: association with influenza virus and respiratory syncytial virus activity Epidemiol. Infect. 136, 1448-1454. (doi:10. 1017/S0950268807000271)
38. Klugman KP, Chien YW, Madhi SA. 2009 Pneumococcal pneumonia and influenza: a deadly combination. Vaccine 27(Suppl. 3), C9-C14. (doi:10.1016/j. vaccine.2009.06.007)
39. Palacios G et al. 2009 Streptococcus pneumoniae coinfection is correlated with the severity of H1N1 pandemic influenza. PLoS ONE 4, e8540. (doi:10. 1371/journal. pone.0008540)
40. Dowell SF, Whitney CG, Wright C, Rose Jr CE, Schuchat A. 2003 Seasonal patterns of invasive pneumococcal disease. Emerg. Infect. Dis. 9, 573-579. (doi:10.3201/eid0905.020556)
41. O'Brien KL, Walters MI, Sellman J, Quinlisk P, Regnery H, Schwartz B, Dowell SF. 2000 Severe pneumococcal pneumonia in previously healthy children: the role of preceding influenza infection. Clin. Infect. Dis. 30, 784-789. (doi:10.1086/313772)
42. McCullers JA. 2006 Insights into the interaction between influenza virus and pneumococcus. Clin. Microbiol. Rev. 19, 571-582. (doi:10.1128/CMR. 00058-05)
43. van der Sluijs KF et al. 2006 Involvement of the platelet-activating factor receptor in host defense against Streptococcus pneumoniae during postinfluenza pneumonia. Am. J. Physiol. Lung Cell Mol. Physiol. 290, L194-199. (doi:10.1152/ajplung. 00050.2005)
44. Sun K, Metzger DW. 2008 Inhibition of pulmonary antibacterial defense by interferon-gamma during recovery from influenza infection. Nat. Med. 14, 558-564. (doi:10.1038/nm1765)
45. van der Sluijs KF, Nijhuis M, Levels JH, Florquin S, Mellor AL, Jansen HM, van der Poll T, Lutter R. 2006 Influenza-induced expression of indoleamine 2,3-dioxygenase enhances interleukin-10 production and bacterial outgrowth during secondary pneumococcal pneumonia. J. Infect. Dis. 193, 214-222. (doi:10.1086/498911)
46. Nakamura S, Davis KM, Weiser JN. 2011 Synergistic stimulation of type I interferons during influenza virus coinfection promotes Streptococcus pneumoniae colonization in mice. J. Clin. Invest. 121, 3657-3665. (doi:10.1172/JCI57762)
47. Bassetti S et al. 2005 Dispersal of Staphylococcus aureus into the air associated with a rhinovirus infection. Infect. Control Hosp. Epidemiol. 26, 196-203. (doi:10.1086/502526)
48. Sherertz RJ, Bassetti S, Bassetti-Wyss B. 2001 'Cloud' health-care workers. Emerg. Infect. Dis. 7, 241-244. (doi:10.3201/eid0702.700241)
49. Trzcinski K, Thompson CM, Gilbey AM, Dowson CG, Lipsitch M. 2006 Incremental increase in fitness cost with increased beta-lactam resistance in pneumococci evaluated by competition in an infant rat nasal colonization model. J. Infect. Dis. 193, 1296-1303. (doi:10.1086/501367)
50. Dagan R, Barkai G, Givon-Lavi N, Sharf AZ, Vardy D, Cohen T, Lipsitch M, Greenberg D. 2008 Seasonality of antibiotic-resistant Streptococcus pneumoniae that causes acute otitis media: a clue for an antibioticrestriction policy J. Infect. Dis. 197, 1094-1102. (doi:10.1086/528995)
51. McCullers JA. 2011 Preventing and treating secondary bacterial infections with antiviral agents. Antivir. Ther. 16, 123-135. (doi:10.3851/IMP1730)